Page last updated: 2024-08-22

vasotocin and Experimental Mammary Neoplasms

vasotocin has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bussolati, G; Cassoni, P; Chini, B; Chinol, M; Nacca, A; Paganelli, G	1

Other Studies

1 other study(ies) available for vasotocin and Experimental Mammary Neoplasms

Article	Year
111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors. Cancer research, 2001, Jun-01, Volume: 61, Issue:11 Topics: Animals; Breast Neoplasms; COS Cells; Female; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Indium Radioisotopes; Isotope Labeling; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Receptors, Oxytocin; Tissue Distribution; Vasotocin	2001

Article

Year

111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.

Cancer research, 2001, Jun-01, Volume: 61, Issue:11

Topics: Animals; Breast Neoplasms; COS Cells; Female; Glioblastoma; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Indium Radioisotopes; Isotope Labeling; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Radiopharmaceuticals; Receptors, Oxytocin; Tissue Distribution; Vasotocin

2001